37 results
Page 2 of 2
6-K
EX-99.3
8y5m0nbtn0o2st9
13 Nov 20
Current report (foreign)
8:03am
424B5
ccoppsi4dpz4fqvjuy
8 Sep 20
Prospectus supplement for primary offering
5:06pm
6-K
EX-99.1
mhic1m
26 Jun 20
Current report (foreign)
4:51pm
6-K
EX-99.1
2hu81x tjm21y10aq
22 May 20
Invitation to the Ordinary Shareholders' Meeting
8:40am
6-K
EX-99.1
jxe15hlop08
2 Apr 20
AC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative Diseases
7:11am
6-K
EX-99.2
l45i5
6 Nov 19
Current report (foreign)
6:48am
6-K
EX-99.1
cy61i
6 Nov 19
Current report (foreign)
6:48am
6-K
EX-99.1
7tle1ln9e9esp
4 Jun 19
Invitation to the Ordinary Shareholders' Meeting
7:22am
6-K
EX-99.3
hsndidib9wafwb7ny
13 Nov 18
Current report (foreign)
6:05am
6-K
EX-99.1
u3227pb
26 Oct 18
Current report (foreign)
5:01pm
6-K
EX-99.3
62di6 9a12sj4kn
8 Aug 18
Current report (foreign)
6:01am
6-K
EX-99.1
hzt06z
17 Jul 18
Updates on AC Immune’s Pipeline and Technology Platforms to be presented at the Alzheimer’s Association International Conference in Chicago
6:00am
6-K
EX-99.1
kk4d5r7
27 Apr 18
Current report (foreign)
4:43pm
20-F
jhgczobxv
17 Mar 17
Annual report (foreign)
12:00am